seed
Stage
1
Investors
About
Amylon Therapeutics develops therapies for central nervous system disorders, with a focus on rare genetic diseases, using RNA modulation technology to treat conditions such as Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch type (HCHWA-D).
Explore Amylon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.